| 书目名称 | Inflammation and Retinal Disease: Complement Biology and Pathology |
| 编辑 | John D. Lambris,Anthony P. Adamis |
| 视频video | |
| 概述 | Comprehensive look at the pathology and biology of retinal inflammation.Written by current, respected opthamologists and eye researchers.Reports on age-related degeneration, gene-associations, and oth |
| 丛书名称 | Advances in Experimental Medicine and Biology |
| 图书封面 |  |
| 描述 | Numerous studies have pointed to the key role of complement in the pathogenesis of retinal disease, particularly age-related macular degeneration (AMD). Reports about new gene associations and links to other physiological pathways are emerging almost on a weekly base. Several promising clinical candidates covering a wide area of potential treatment applications are in the pipelines of both industrial and academic groups. This indicates an increasing interest in complement as a therapeutic target. In view of these exciting discoveries, scientists from around the world convened at the First Aegean Conferences Conference on Inflammation and Retinal Disease: Complement Biology and Pathology (June 10–17, 2007) in Crete, Greece, to discuss recent advances in this rapidly-evolving field. This volume represents a collection of topics on the functions of complement in eye diseases, pathophysiology, protein structures, and complement therapeutics discussed during the conference. Our sincere thanks to the contributing authors for the time and effort they have devoted to writing what I consider exceptionally informative chapters in a book that will have a significant impact on the complement f |
| 出版日期 | Conference proceedings 2010 |
| 关键词 | eye; macular degeneration; pathogenesis; pathology; retina |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-1-4419-5635-4 |
| isbn_softcover | 978-1-4614-2648-6 |
| isbn_ebook | 978-1-4419-5635-4Series ISSN 0065-2598 Series E-ISSN 2214-8019 |
| issn_series | 0065-2598 |
| copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Busines |
发表于 2025-3-21 18:30:28
